Drug use and screening in pediatric trauma

Kathryn Martin, Kelly N. Vogt, Murray J. Girotti, Tanya C. Stewart, Neil G. Parry

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: There is a paucity of research on substance use in the pediatric trauma population. This study aims to describe trends in substance use and screening in the Canadian pediatric trauma population. Materials and Methods: A retrospective review of the London Health Sciences Centre trauma database from April 1999 to January 2009 identified patients less than 18 years old admitted after major trauma [injury severity score (ISS) > 12]. Data extracted included age, gender, ISS, blood alcohol concentration (BAC), and results of toxicology screens. Results: BAC data were available for 799 patients and toxicology screens for 761 patients. BAC testing was completed in 30% (21% positive). Toxicology screens were completed in 7% (44% positive). Increasing age was associated with screening for alcohol (odds ratio = 1.4; 95% confidence interval 1.3-1.5). Screening for drug use had a bimodal distribution, with no children aged 4-10 years screened. Those screened for drugs and alcohol had a significantly higher ISS than those not tested (BAC 28 versus 23, P < 0.001, toxin screening 29 versus 24, P = 0.003). The most common ingestions were alcohol, benzodiazepines, cannabinoids, and opiates. Conclusions: Screening for drugs and alcohol is sporadic in the pediatric trauma population. Further study utilizing a universal approach to drug and alcohol screening is needed to further delineate the true prevalence of substance use in this population.

Original languageEnglish (US)
Pages (from-to)439-442
Number of pages4
JournalTherapeutic Drug Monitoring
Volume33
Issue number4
DOIs
StatePublished - Aug 1 2011

Fingerprint

Preclinical Drug Evaluations
Alcohols
Injury Severity Score
Pediatrics
Toxicology
Wounds and Injuries
Population
Opiate Alkaloids
Cannabinoids
Trauma Centers
Benzodiazepines
Eating
Odds Ratio
Databases
Confidence Intervals
Blood Alcohol Content
Health
Research
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Martin, K., Vogt, K. N., Girotti, M. J., Stewart, T. C., & Parry, N. G. (2011). Drug use and screening in pediatric trauma. Therapeutic Drug Monitoring, 33(4), 439-442. https://doi.org/10.1097/FTD.0b013e318222d951
Martin, Kathryn ; Vogt, Kelly N. ; Girotti, Murray J. ; Stewart, Tanya C. ; Parry, Neil G. / Drug use and screening in pediatric trauma. In: Therapeutic Drug Monitoring. 2011 ; Vol. 33, No. 4. pp. 439-442.
@article{ba300800638b422492d186b56f198620,
title = "Drug use and screening in pediatric trauma",
abstract = "Background: There is a paucity of research on substance use in the pediatric trauma population. This study aims to describe trends in substance use and screening in the Canadian pediatric trauma population. Materials and Methods: A retrospective review of the London Health Sciences Centre trauma database from April 1999 to January 2009 identified patients less than 18 years old admitted after major trauma [injury severity score (ISS) > 12]. Data extracted included age, gender, ISS, blood alcohol concentration (BAC), and results of toxicology screens. Results: BAC data were available for 799 patients and toxicology screens for 761 patients. BAC testing was completed in 30{\%} (21{\%} positive). Toxicology screens were completed in 7{\%} (44{\%} positive). Increasing age was associated with screening for alcohol (odds ratio = 1.4; 95{\%} confidence interval 1.3-1.5). Screening for drug use had a bimodal distribution, with no children aged 4-10 years screened. Those screened for drugs and alcohol had a significantly higher ISS than those not tested (BAC 28 versus 23, P < 0.001, toxin screening 29 versus 24, P = 0.003). The most common ingestions were alcohol, benzodiazepines, cannabinoids, and opiates. Conclusions: Screening for drugs and alcohol is sporadic in the pediatric trauma population. Further study utilizing a universal approach to drug and alcohol screening is needed to further delineate the true prevalence of substance use in this population.",
author = "Kathryn Martin and Vogt, {Kelly N.} and Girotti, {Murray J.} and Stewart, {Tanya C.} and Parry, {Neil G.}",
year = "2011",
month = "8",
day = "1",
doi = "10.1097/FTD.0b013e318222d951",
language = "English (US)",
volume = "33",
pages = "439--442",
journal = "Therapeutic Drug Monitoring",
issn = "0163-4356",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

Martin, K, Vogt, KN, Girotti, MJ, Stewart, TC & Parry, NG 2011, 'Drug use and screening in pediatric trauma', Therapeutic Drug Monitoring, vol. 33, no. 4, pp. 439-442. https://doi.org/10.1097/FTD.0b013e318222d951

Drug use and screening in pediatric trauma. / Martin, Kathryn; Vogt, Kelly N.; Girotti, Murray J.; Stewart, Tanya C.; Parry, Neil G.

In: Therapeutic Drug Monitoring, Vol. 33, No. 4, 01.08.2011, p. 439-442.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Drug use and screening in pediatric trauma

AU - Martin, Kathryn

AU - Vogt, Kelly N.

AU - Girotti, Murray J.

AU - Stewart, Tanya C.

AU - Parry, Neil G.

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Background: There is a paucity of research on substance use in the pediatric trauma population. This study aims to describe trends in substance use and screening in the Canadian pediatric trauma population. Materials and Methods: A retrospective review of the London Health Sciences Centre trauma database from April 1999 to January 2009 identified patients less than 18 years old admitted after major trauma [injury severity score (ISS) > 12]. Data extracted included age, gender, ISS, blood alcohol concentration (BAC), and results of toxicology screens. Results: BAC data were available for 799 patients and toxicology screens for 761 patients. BAC testing was completed in 30% (21% positive). Toxicology screens were completed in 7% (44% positive). Increasing age was associated with screening for alcohol (odds ratio = 1.4; 95% confidence interval 1.3-1.5). Screening for drug use had a bimodal distribution, with no children aged 4-10 years screened. Those screened for drugs and alcohol had a significantly higher ISS than those not tested (BAC 28 versus 23, P < 0.001, toxin screening 29 versus 24, P = 0.003). The most common ingestions were alcohol, benzodiazepines, cannabinoids, and opiates. Conclusions: Screening for drugs and alcohol is sporadic in the pediatric trauma population. Further study utilizing a universal approach to drug and alcohol screening is needed to further delineate the true prevalence of substance use in this population.

AB - Background: There is a paucity of research on substance use in the pediatric trauma population. This study aims to describe trends in substance use and screening in the Canadian pediatric trauma population. Materials and Methods: A retrospective review of the London Health Sciences Centre trauma database from April 1999 to January 2009 identified patients less than 18 years old admitted after major trauma [injury severity score (ISS) > 12]. Data extracted included age, gender, ISS, blood alcohol concentration (BAC), and results of toxicology screens. Results: BAC data were available for 799 patients and toxicology screens for 761 patients. BAC testing was completed in 30% (21% positive). Toxicology screens were completed in 7% (44% positive). Increasing age was associated with screening for alcohol (odds ratio = 1.4; 95% confidence interval 1.3-1.5). Screening for drug use had a bimodal distribution, with no children aged 4-10 years screened. Those screened for drugs and alcohol had a significantly higher ISS than those not tested (BAC 28 versus 23, P < 0.001, toxin screening 29 versus 24, P = 0.003). The most common ingestions were alcohol, benzodiazepines, cannabinoids, and opiates. Conclusions: Screening for drugs and alcohol is sporadic in the pediatric trauma population. Further study utilizing a universal approach to drug and alcohol screening is needed to further delineate the true prevalence of substance use in this population.

UR - http://www.scopus.com/inward/record.url?scp=80051801548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051801548&partnerID=8YFLogxK

U2 - 10.1097/FTD.0b013e318222d951

DO - 10.1097/FTD.0b013e318222d951

M3 - Article

VL - 33

SP - 439

EP - 442

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

SN - 0163-4356

IS - 4

ER -